首頁 > 市場調查報告書 > 醫療設備

e保健

感染監控解決方案市場 - 2018-2028 年全球產業規模、佔有率、趨勢、機會和預測，按產品（軟體、服務）、最終用戶（醫院、長期照護設施）、地區和競爭細分

市場調查報告書

商品編碼

1370959

感染監控解決方案市場 - 2018-2028 年全球產業規模、佔有率、趨勢、機會和預測，按產品（軟體、服務）、最終用戶（醫院、長期照護設施）、地區和競爭細分

Infection Surveillance Solutions Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Offering (Software, Service), By End User (Hospitals, Long-term Care Facilities), By Region and Competition

出版日期: 2023年10月03日 | 出版商:

TechSci Research | 英文 190 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2022 年，全球感染監測解決方案市場估值達到 5.5721 億美元，並預計在預測期內強勁成長，預計年複合成長率 (CAGR) 為 11.16%，預計到 2028 年將達到 105198 萬美元。感染監測解決方案是包括醫院在內的醫療機構使用的軟體，用於向州和聯邦當局報告病患資料。這些解決方案透過收集醫院感染資料、研究感染模式並調節其在社區內的傳播，在醫療保健產業中發揮著至關重要的作用。院內感染是指在醫院或醫療中心內傳播給個人的感染。一旦發生感染，該軟體會立即向醫院的網際網路協議 (IP) 地址發出警報，使 HAI 專家和護士能夠及時為受感染的患者提供適當的治療，防止疫情爆發。感染監測解決方案是促進醫療機構中醫療保健獲得性感染 (HAI) 有效管理的重要計劃。 HAI 的常見例子包括肺炎、胃腸道疾病、泌尿道感染、原發性血流感染和手術後感染。醫院感染的高發生率是世界各國政府關注的重大議題，因此制定了旨在有效管理和減少這些事件的政策。

主要市場促進因素：

1.院內感染盛行率不斷上升：院內感染 (HAI) 盛行率不斷上升，推動了對感染監測解決方案的需求。 HAI，也稱為醫療保健相關感染，是患者在醫療機構接受治療時發生的感染。這些感染可能導致住院時間延長、醫療費用增加、病患不適，嚴重時甚至導致死亡。為了應對這一日益成長的擔憂，人們正在尋求感染監測解決方案來幫助預防、監測和管理 HAI。

市場概況
預測期	2024-2028
2022 年市場規模	5.5721億美元
2028 年市場規模	105198萬美元
2023-2028 年年複合成長率	11.16%
成長最快的細分市場	重症監護室/重症監護室
最大的市場	北美洲

2.手術數量的增加：手術數量的增加推動了對感染監測解決方案的需求。手術有術後感染的風險，可能導致併發症、延長住院時間、增加醫療費用和患者不適。感染監測解決方案在監測和預防醫院感染（包括外科手術後發生的醫院感染）方面發揮關鍵作用。外科手術會將病原體引入體內，增加手術部位感染的風險。感染監測解決方案可協助醫療機構監測手術部位並及早發現感染，以便及時採取介入措施。
3.政府對跨醫療機構的 IPC 計劃的舉措和投資不斷增加：世界各地的政府正在實施政策和法規，以製定長期感染預防和控制計劃，並就最佳實踐對醫療保健提供者進行教育。除了維護公共統計記錄外，政府還向醫療中心和組織提供資金，用於安裝先進的感染監測軟體。這些措施使不同規模的醫療機構能夠有效地利用尖端工具，促進感染控制監測解決方案市場的成長。
4.透過人工智慧整合增加投資以改善醫療保健系統：對醫療保健系統的投資優先考慮病人安全和護理品質。感染監測解決方案在識別和預防 HAI 方面發揮著至關重要的作用，有助於改善病患安全結果。醫療保健系統正致力於品質改善舉措，以減少不良事件，包括醫院感染。由於住院時間延長、額外治療和再次入院，醫院感染導致醫療費用增加。對感染監測解決方案的投資可以透過預防感染及其相關併發症來顯著節省成本。
5.基於雲端的軟體解決方案：基於雲端的軟體解決方案預計將在未來顯著推動感染監控解決方案（ISS）市場的發展。雲端技術提供可擴展性、節省成本和遠端存取優勢，非常符合醫療保健組織尋求高效且可擴展的感染監測解決方案的需求。
6.醫療保健產業的整合不斷加強：醫療保健產業的整合不斷加強，預計將推動感染監測解決方案(ISS) 市場的發展，因為醫療保健組織尋求ISS 等標準化實踐和技術解決方案，以確保對感染進行一致的監測和管理。

細分洞見：

產品類型洞察：市場分為軟體和服務。 2022 年，軟體細分市場佔據主導地位，而服務細分市場預計將在預測期內表現出更高的年複合成長率 (CAGR)。軟體領域的成長可歸因於不同配置的可用性、快速投資回報和即時分析等優勢。

最終用戶洞察：醫院代表著最大的市場佔有率，並且在預測期內呈現最高的成長率。包括手術部位感染 (SSI) 在內的醫療保健相關感染 (HAI) 的盛行促進了醫院市場的成長。

塞納公司
史詩系統公司
維吉蘭茲公司
貝克頓迪金森公司
普瑞米爾公司
DEBGroup Limited
強化學習解決方案
百特國際公司（ICNet International）
五條工業公司
IBM 公司（特魯文健康分析）

報告範圍：

在本報告中，除了以下詳細介紹的產業趨勢外，全球感染監控解決方案市場也分為以下幾類。

感染監控解決方案市場，透過提供：

軟體
服務

感染監控解決方案市場，依最終用戶分類：

醫院
長期照護設施

感染監控解決方案市場（按地區）：

北美洲
美國
加拿大
墨西哥
歐洲
法國
英國
義大利
德國
西班牙
亞太
中國
印度
日本
澳洲
韓國
南美洲
巴西
阿根廷
哥倫比亞
中東和非洲
南非
沙烏地阿拉伯
阿拉伯聯合大公國
科威特
土耳其
埃及

競爭格局

公司概況：對全球感染監控解決方案市場中主要公司的詳細分析。

可用的客製化：

全球感染監測解決方案市場報告以及給定的市場資料，TechSci Research 根據公司的具體需求提供客製化服務。該報告可以使用以下自訂選項：

公司資訊

其他市場參與者（最多五個）的詳細分析和概況分析。

商業概覽
服務內容
最近的發展
主要人員
SWOT分析
- Cerner Corporation
- Epic Systems Corporation
- VigiLanz Corporation
- Becton, Dickinson and Company
- Premier Inc.
- DEB Group Ltd
- RL Solutions
- Baxter International Inc. (ICNet International)
- Gojo Industries Inc.
- IBM Corporation (Truven Health Analytics)

第 16 章：策略建議

第 17 章：關於我們與免責聲明

簡介目錄

Product Code: 4823

Global Infection Surveillance Solutions Market has valued at USD 557.21 Million in 2022 and is anticipated to project robust growth in the forecast period with a CAGR of 9.86% through 2028. An infection surveillance solution is a software used by healthcare facilities, including hospitals, to report patient data to state and federal authorities. These solutions play a crucial role in the healthcare industry by collecting data on nosocomial infections, studying infection patterns, and regulating their spread within the community. Nosocomial infections are infections transmitted to individuals within hospitals or healthcare centers. This software promptly alerts hospital Internet Protocol (IP) addresses in the event of infection occurrences. This enables HAI specialists and nurses to promptly provide appropriate treatment to infected patients, preventing outbreaks. Infection surveillance solutions are vital programs that facilitate the effective management of Healthcare-Acquired Infections (HAIs) in healthcare facilities. Common examples of HAIs include pneumonia, gastrointestinal illness, urinary tract infections, primary bloodstream infections, and post-surgical infections. The high incidence of HAIs is a significant concern for governments worldwide, leading to the development of policies aimed at effectively managing and reducing these incidents.

Key Market Drivers

Increasing Prevalence of Hospital-Acquired Infections

Market Overview
Forecast Period	2024-2028
Market Size 2022	USD 557.21 Million
Market Size 2028	USD 975.33 Million
CAGR 2023-2028	9.86%
Fastest Growing Segment	Hospitals
Largest Market	North America

The increasing prevalence of hospital-acquired infections (HAIs) is driving the demand for infection surveillance solutions. Hospital-acquired infections, also known as healthcare-associated infections, are infections that patients acquire while receiving medical treatment in healthcare facilities. These infections can lead to prolonged hospital stays, increased healthcare costs, patient discomfort, and, in severe cases, even mortality. In response to this growing concern, infection surveillance solutions are being sought after to help prevent, monitor, and manage HAIs. HAIs pose a significant threat to patient safety and well-being. The rising awareness of these concerns has prompted healthcare facilities to prioritize infection control.

The increasing emphasis on hospital safety is driving the market for infection control surveillance solutions. Hospitals are actively seeking ways to enhance patient safety and reduce infection rates through improved surveillance strategies. This transformation commenced in the late 2000s with the introduction of electronic medical record systems, which allowed for more efficient and accurate patient data collection. Presently, hospitals are investing in advanced solutions to detect and predict infections, implement evidence-based protocols, and monitor outcomes over time. These solutions leverage data analytics, AI, ML, and predictive modeling to facilitate accurate identification and mitigation of infection risks. Apart from enhancing patient safety, these solutions offer potential benefits such as cost reduction, operational efficiency improvement, and optimization of care quality.

Increasing Number of Surgeries

The increasing number of surgeries is driving the demand for infection surveillance solutions. Surgeries, while often necessary for medical treatment, carry a risk of post-operative infections, which can lead to complications, extended hospital stays, increased healthcare costs, and patient discomfort. Infection surveillance solutions play a critical role in monitoring and preventing healthcare-associated infections (HAIs), including those that occur after surgical procedures. Surgical procedures can introduce pathogens into the body, increasing the risk of infections at the surgical site. Infection surveillance solutions help healthcare facilities monitor surgical sites and detect infections early, leading to prompt interventions. Surgical site infections can lead to complications such as wound dehiscence, sepsis, and prolonged recovery. Effective infection surveillance solutions aid in preventing these complications, improving patient outcomes. Surgeons and healthcare professionals rely on data-driven insights to make informed decisions. Infection surveillance solutions provide real-time data and analytics to monitor infection trends, identify potential outbreaks, and inform clinical decisions. The increasing number of surgeries amplifies the importance of infection surveillance solutions in preventing post-operative infections and improving patient outcomes. As healthcare facilities recognize the impact of infection control on patient safety, quality of care, and financial sustainability, the demand for these solutions is expected to continue to rise.

Growing Government Initiatives & Investment in IPC Programs Across Healthcare Settings

Infection surveillance solutions are utilized in healthcare settings to empower healthcare professionals in predicting and preventing the transmission of infectious diseases. By early detection, evaluating intervention effectiveness, and identifying risk reduction tools, these solutions play a crucial role. Governments worldwide are implementing policies and regulations to develop long-term prevention programs and educate healthcare providers on infection prevention and control best practices. In addition to maintaining public statistical records, governments offer funding to healthcare centers and organizations for advanced infection surveillance software installation. These initiatives enable healthcare facilities of varying sizes to efficiently utilize cutting-edge tools, contributing to the growth of the infection control surveillance solutions market.

Growing Investments to Improve Healthcare Systems by AI integration

Investments in healthcare systems often prioritize patient safety and quality of care. Infection surveillance solutions play a vital role in identifying and preventing healthcare-associated infections (HAIs), thus contributing to improved patient safety outcomes. Healthcare systems are focusing on quality improvement initiatives to reduce adverse events, including HAIs. Infection surveillance solutions provide real-time monitoring, data analysis, and early detection of potential outbreaks, supporting these initiatives. HAIs lead to increased healthcare costs due to prolonged hospital stays, additional treatments, and readmissions. Investments in infection surveillance solutions can lead to significant cost savings by preventing infections and their associated complications.

Cloud-based and AI-integrated infection surveillance and control software is a critical technology that empowers public health organizations to swiftly and effectively detect and respond to infections. Over the years, advancements in cloud-based and AI-integrated software have significantly enhanced the efficacy and efficiency of infection surveillance and control. By leveraging cloud-based solutions, public health organizations can efficiently and securely store and manage large volumes of data. Furthermore, real-time access to this data enables more responsive action during outbreaks. Another notable progress in cloud-based and AI-integrated infection surveillance and control software is the integration of machine learning algorithms. These algorithms enable public health organizations to derive more comprehensive insights from the data, facilitating a better understanding of underlying infection patterns and informed response strategies.

Key Market Challenges

High Cost of Deployment for Small Healthcare Organizations

The high cost of deployment for small healthcare organizations is a significant factor restraining the growth of Infection Surveillance Solutions (ISS). These solutions often require initial investment in technology, infrastructure, staff training, and ongoing maintenance. For small healthcare organizations with limited budgets and resources, the cost of implementing and sustaining infection surveillance solutions can be a barrier to adoption. Small healthcare organizations often operate with tighter budgets compared to larger institutions. The high upfront and ongoing costs associated with infection surveillance solutions can strain their financial resources, making it difficult to allocate funds for implementation. Small healthcare organizations may need to prioritize their resources for essential services and treatments. Investing in infection surveillance solutions might divert resources away from other critical needs, making the decision challenging. Beyond the initial deployment, infection surveillance solutions require ongoing maintenance, updates, and technical support. Small healthcare organizations might struggle to allocate resources for these continuous operational needs.

Data Security Concerns

Infection surveillance solutions require the collection and storage of patient health data, including personal and medical information. Ensuring the privacy of this data is crucial to maintain patient trust and comply with regulations like the Health Insurance Portability and Accountability Act (HIPAA) in the United States. Healthcare organizations are subject to strict data protection regulations and standards, which can vary by region. Failure to comply with these regulations can lead to severe penalties. Implementing ISS while ensuring compliance adds complexity and cost to the process. The software and hardware used in ISS solutions can have vulnerabilities that hackers could exploit to gain unauthorized access. Addressing these vulnerabilities requires continuous monitoring, updates, and security measures. Many ISS solutions involve third-party vendors and cloud services for data storage and management. This introduces additional security concerns, as healthcare organizations need to trust that these vendors have robust security measures in place.

Key Market Trends

Cloud-based Software Solutions

Cloud-based software solutions are expected to significantly boost the Infection Surveillance Solutions (ISS) market in the future. Cloud technology offers a range of benefits that align well with the needs of healthcare organizations seeking efficient and scalable infection surveillance solutions. Cloud-based solutions offer scalability to accommodate the varying needs of healthcare organizations, whether they are small clinics or large hospitals. As the demand for infection surveillance solutions grows, cloud platforms can easily scale up to handle increased data volume and user activity. Traditional on-premises software solutions require significant investments in hardware, servers, and IT infrastructure. Cloud-based solutions eliminate these upfront costs, making ISS more accessible to healthcare organizations with limited resources. Cloud-based solutions are typically quicker to implement compared to on-premises alternatives. This is particularly advantageous for healthcare organizations looking to deploy infection surveillance solutions rapidly. Cloud-based solutions provide remote access to infection surveillance data for authorized personnel. Healthcare professionals can securely access and monitor infection data from various locations, enabling more efficient and timely interventions. Cloud-based infection surveillance solutions enable real-time monitoring of infection trends, allowing healthcare organizations to respond promptly to potential outbreaks and implement necessary interventions.

Increasing Consolidation in The Healthcare Industry

Increasing consolidation in the healthcare industry is expected to boost the Infection Surveillance Solutions (ISS) market in the future. Healthcare industry consolidation refers to the merging of hospitals, healthcare systems, and medical facilities into larger entities. As healthcare organizations consolidate, there is a greater focus on standardizing practices across different facilities. This includes infection control protocols and the adoption of common technology solutions like ISS to ensure consistent monitoring and management of infections. Consolidated healthcare entities often seek to integrate and share patient data seamlessly. Infection surveillance solutions that offer interoperability and data sharing capabilities are crucial for tracking infections across different departments and locations.

Segmental Insights

Product Type Insights

Based on the offering, the market is categorized into software and services. In 2022, the software segment dominated the market. Conversely, the services segment is projected to demonstrate a higher Compound Annual Growth Rate (CAGR) during the forecast period, owing to the increased adoption of software packages in healthcare facilities. The software segment is expected to witness the highest CAGR throughout the forecast period. This growth can be attributed to its advantages over on-premises software, including availability in different configurations, rapid return on investment, and real-time analysis. Furthermore, healthcare IT companies are introducing innovative solutions in data management, analytics, and infrastructure, facilitating easier data collection of electronic health records (EHR), infection, and epidemic trends through their software packages.

End User Insights

The infection surveillance solutions market, categorized by end user, is divided into hospitals, and long-term care facilities. Among these, the hospitals segment holds the largest market share and exhibits the highest growth rate during the forecast period. The significant prevalence of healthcare-associated infections (HAIs) and the subsequent financial burden on stakeholders have propelled the adoption of infection control products and services in hospitals. Additionally, the substantial patient volume and the increasing incidence of surgical site infections (SSIs) contribute to the market's growth. Notable HAIs commonly reported in hospitals include central line-associated bloodstream infections, methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci bloodstream infections, Clostridium difficile infections, and SSIs.

Regional Insights

The North American region has demonstrated dominance in market share compared to other regions. This can be attributed to strict regulations and the presence of numerous firms offering infection surveillance solutions in the region. The government's substantial investment in healthcare has led to an increase in the number of healthcare centers. On the other hand, the APAC region is experiencing the highest growth rate. This can be attributed to increased health awareness, higher healthcare expenditure, a growing number of healthcare centers, and significant improvements in health insurance.

Key Market Players

Cerner Corporation

Epic Systems Corporation

VigiLanz Corporation

Becton, Dickinson and Company

Premier Inc.

DEB Group Ltd

RL Solutions

Baxter International Inc. (ICNet International)

Gojo Industries Inc.

IBM Corporation (Truven Health Analytics)

Report Scope:

In this report, the Global Infection Surveillance Solutions Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Infection Surveillance Solutions Market, By Offering:

Software
Service

Infection Surveillance Solutions Market, By End User:

Hospitals
Long-term Care Facilities

Infection Surveillance Solutions Market, By Region:

North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia-Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
Turkey
Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Infection Surveillance Solutions Market.

Available Customizations:

Global Infection Surveillance Solutions market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Infection Surveillance Solutions Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Offering (Software, Service)
- 5.2.2. By End User (Hospitals, Long-term Care Facilities)
- 5.2.3. By Region
- 5.2.4. By Company (2022)
5.3. Market Map

6. North America Infection Surveillance Solutions Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Offering
- 6.2.2. By End User
- 6.2.3. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Infection Surveillance Solutions Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Offering
    - 6.3.1.2.2. By End User
- 6.3.2. Canada Infection Surveillance Solutions Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Offering
    - 6.3.2.2.2. By End User
- 6.3.3. Mexico Infection Surveillance Solutions Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Offering
    - 6.3.3.2.2. By End User

7. Europe Infection Surveillance Solutions Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Offering
- 7.2.2. By End User
- 7.2.3. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Infection Surveillance Solutions Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Offering
    - 7.3.1.2.2. By End User
- 7.3.2. United Kingdom Infection Surveillance Solutions Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Offering
    - 7.3.2.2.2. By End User
- 7.3.3. Italy Infection Surveillance Solutions Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecasty
    - 7.3.3.2.1. By Offering
    - 7.3.3.2.2. By End User
- 7.3.4. France Infection Surveillance Solutions Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Offering
    - 7.3.4.2.2. By End User
- 7.3.5. Spain Infection Surveillance Solutions Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Offering
    - 7.3.5.2.2. By End User

8. Asia-Pacific Infection Surveillance Solutions Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Offering
- 8.2.2. By End User
- 8.2.3. By Country
8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Infection Surveillance Solutions Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Offering
    - 8.3.1.2.2. By End User
- 8.3.2. India Infection Surveillance Solutions Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Offering
    - 8.3.2.2.2. By End User
- 8.3.3. Japan Infection Surveillance Solutions Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Offering
    - 8.3.3.2.2. By End User
- 8.3.4. South Korea Infection Surveillance Solutions Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Offering
    - 8.3.4.2.2. By End User
- 8.3.5. Australia Infection Surveillance Solutions Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Offering
    - 8.3.5.2.2. By End User

9. South America Infection Surveillance Solutions Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Offering
- 9.2.2. By End User
- 9.2.3. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil Infection Surveillance Solutions Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Offering
    - 9.3.1.2.2. By End User
- 9.3.2. Argentina Infection Surveillance Solutions Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Offering
    - 9.3.2.2.2. By End User
- 9.3.3. Colombia Infection Surveillance Solutions Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Offering
    - 9.3.3.2.2. By End User

10. Middle East and Africa Infection Surveillance Solutions Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Offering
- 10.2.2. By End User
- 10.2.3. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa Infection Surveillance Solutions Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Offering
    - 10.3.1.2.2. By End User
- 10.3.2. Saudi Arabia Infection Surveillance Solutions Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Offering
    - 10.3.2.2.2. By End User
- 10.3.3. UAE Infection Surveillance Solutions Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Offering
    - 10.3.3.2.2. By End User

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches

13. Global Infection Surveillance Solutions Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Business Overview
15.2. Service Offerings
15.3. Recent Developments
15.4. Key Personnel
15.5. SWOT Analysis
- 15.5.1. Cerner Corporation
- 15.5.2. Epic Systems Corporation
- 15.5.3. VigiLanz Corporation
- 15.5.4. Becton, Dickinson and Company
- 15.5.5. Premier Inc.
- 15.5.6. DEB Group Ltd
- 15.5.7. RL Solutions
- 15.5.8. Baxter International Inc. (ICNet International)
- 15.5.9. Gojo Industries Inc.
- 15.5.10. IBM Corporation (Truven Health Analytics)